Endothelial cell &agr;-globin and its molecular chaperone &agr;-hemoglobin–stabilizing protein regulate arteriolar contractility

Arteriolar endothelial cell–expressed (EC-expressed) &agr;-globin binds endothelial NOS (eNOS) and degrades its enzymatic product, NO, via dioxygenation, thereby lessening the vasodilatory effects of NO on nearby vascular smooth muscle. Although this reaction potentially affects vascular physiology, the mechanisms that regulate &agr;-globin expression and dioxygenase activity in ECs are unknown. Without &bgr;-globin, &agr;-globin is unstable and cytotoxic, particularly in its oxidized form, which is generated by dioxygenation and recycled via endogenous reductases. We show that the molecular chaperone &agr;-hemoglobin–stabilizing protein (AHSP) promotes arteriolar &agr;-globin expression in vivo and facilitates its reduction by eNOS. In Ahsp−/− mice, EC &agr;-globin was decreased by 70%. Ahsp−/− and Hba1−/− mice exhibited similar evidence of increased vascular NO signaling, including arteriolar dilation, blunted &agr;1-adrenergic vasoconstriction, and reduced blood pressure. Purified &agr;-globin bound eNOS or AHSP, but not both together. In ECs in culture, eNOS or AHSP enhanced &agr;-globin expression posttranscriptionally. However, only AHSP prevented oxidized &agr;-globin precipitation in solution. Finally, eNOS reduced AHSP-bound &agr;-globin approximately 6-fold faster than did the major erythrocyte hemoglobin reductases (cytochrome B5 reductase plus cytochrome B5). Our data support a model whereby redox-sensitive shuttling of EC &agr;-globin between AHSP and eNOS regulates EC NO degradation and vascular tone.

[1]  Megan P. Miller,et al.  Targeting Pulmonary Endothelial Hemoglobin &agr; Improves Nitric Oxide Signaling and Reverses Pulmonary Artery Endothelial Dysfunction , 2017, American Journal of Respiratory Cell and Molecular Biology.

[2]  M. Gladwin,et al.  Efficient Reduction of Vertebrate Cytoglobins by the Cytochrome b5/Cytochrome b5 Reductase/NADH System. , 2017, Biochemistry.

[3]  J. ReederBrandon,et al.  Redox and Peroxidase Activities of the Hemoglobin Superfamily: Relevance to Health and Disease. , 2017, Antioxidants & redox signaling.

[4]  Xiaoping Liu,et al.  Cytoglobin regulates blood pressure and vascular tone through nitric oxide metabolism in the vascular wall , 2017, Nature Communications.

[5]  L. Smeeth,et al.  Blood Pressure and Arterial Stiffness in Kenyan Adolescents With α+Thalassemia , 2017, Journal of the American Heart Association.

[6]  A. Orekhov,et al.  Effects of shear stress on endothelial cells: go with the flow , 2017, Acta physiologica.

[7]  N. Tsoukias,et al.  Can endothelial hemoglobin-α regulate nitric oxide vasodilatory signaling? , 2017, American journal of physiology. Heart and circulatory physiology.

[8]  S. Peirce,et al.  Modulating Vascular Hemodynamics With an Alpha Globin Mimetic Peptide (Hb&agr;X) , 2016, Hypertension.

[9]  D. Higgs,et al.  Understanding α‐globin gene regulation and implications for the treatment of β‐thalassemia , 2016, Annals of the New York Academy of Sciences.

[10]  Megan P. Miller,et al.  Hemoglobin &agr;/eNOS Coupling at Myoendothelial Junctions Is Required for Nitric Oxide Scavenging During Vasoconstriction , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[11]  K. Reddy,et al.  Hemoglobin Expression in Nonerythroid Cells: Novel or Ubiquitous? , 2014, International journal of inflammation.

[12]  E. Zuiderweg,et al.  Protein/Protein Interactions in the Mammalian Heme Degradation Pathway , 2014, The Journal of Biological Chemistry.

[13]  J. Beers,et al.  Hemoglobin α in the blood vessel wall. , 2014, Free radical biology & medicine.

[14]  L. Kiger,et al.  Dynamics of α-Hb chain binding to its chaperone AHSP depends on heme coordination and redox state. , 2014, Biochimica et biophysica acta.

[15]  Daniel B Kim-Shapiro,et al.  Hemoglobin-mediated nitric oxide signaling. , 2013, Free radical biology & medicine.

[16]  Jason A. Lowry,et al.  α-Hemoglobin-stabilizing Protein (AHSP) Perturbs the Proximal Heme Pocket of Oxy-α-hemoglobin and Weakens the Iron-Oxygen Bond* , 2013, The Journal of Biological Chemistry.

[17]  M. Weiss,et al.  α-Hemoglobin Stabilizing Protein (AHSP) Markedly Decreases the Redox Potential and Reactivity of α-Subunits of Human HbA with Hydrogen Peroxide* , 2012, The Journal of Biological Chemistry.

[18]  B. Gaston,et al.  Endothelial cell expression of hemoglobin α regulates nitric oxide signaling , 2012, Nature.

[19]  M. Weiss,et al.  Integrated protein quality-control pathways regulate free α-globin in murine β-thalassemia. , 2012, Blood.

[20]  M. Billaud,et al.  Characterization of the Thoracodorsal Artery: Morphology and Reactivity , 2012, Microcirculation.

[21]  John S. Olson,et al.  Kinetics of α-Globin Binding to α-Hemoglobin Stabilizing Protein (AHSP) Indicate Preferential Stabilization of Hemichrome Folding Intermediate* , 2012, The Journal of Biological Chemistry.

[22]  D. Gell,et al.  Insights into Hemoglobin Assembly through in Vivo Mutagenesis of α-Hemoglobin Stabilizing Protein* , 2012, The Journal of Biological Chemistry.

[23]  E. Bridenbaugh,et al.  Isolation and preparation of RNA from rat blood and lymphatic microvessels for use in microarray analysis. , 2012, Methods in molecular biology.

[24]  E. Cairrão,et al.  Cyclic nucleotide-dependent relaxation pathways in vascular smooth muscle , 2011, Cellular and Molecular Life Sciences.

[25]  M. Weiss,et al.  Protein quality control during erythropoiesis and hemoglobin synthesis. , 2010, Hematology/oncology clinics of North America.

[26]  S. Daff.  NO synthase: structures and mechanisms. , 2010, Nitric oxide : biology and chemistry.

[27]  Laurent Kiger,et al.  α-Hemoglobin Stabilizing Protein (AHSP), a Kinetic Scheme of the Action of a Human Mutant, AHSPV56G* , 2010, The Journal of Biological Chemistry.

[28]  N. Leitinger,et al.  Plasminogen Activator Inhibitor-1 Regulates Myoendothelial Junction Formation , 2010, Circulation research.

[29]  M. Weiss,et al.  The role of alpha-hemoglobin stabilizing protein in redox chemistry, denaturation, and hemoglobin assembly. , 2010, Antioxidants & redox signaling.

[30]  M. Haque,et al.  Structural and mechanistic aspects of flavoproteins: electron transfer through the nitric oxide synthase flavoprotein domain , 2009, The FEBS journal.

[31]  Perdeep K. Mehta,et al.  Amelioration of murine beta-thalassemia through drug selection of hematopoietic stem cells transduced with a lentiviral vector encoding both gamma-globin and the MGMT drug-resistance gene. , 2009, Blood.

[32]  B. Isakson,et al.  The Myoendothelial Junction: Breaking through the Matrix? , 2009, Microcirculation.

[33]  J. Gray,et al.  Correction of Murine Sickle Cell Disease Using γ-Globin Lentiviral Vectors to Mediate High-level Expression of Fetal Hemoglobin. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[34]  Donald G Welsh,et al.  WHAT'S WHERE AND WHY AT A VASCULAR MYOENDOTHELIAL MICRODOMAIN SIGNALLING COMPLEX , 2009, Clinical and experimental pharmacology & physiology.

[35]  J. Gray,et al.  Correction of murine sickle cell disease using gamma-globin lentiviral vectors to mediate high-level expression of fetal hemoglobin. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[36]  L. Moens,et al.  Diversity of Globin Function: Enzymatic, Transport, Storage, and Sensing* , 2008, Journal of Biological Chemistry.

[37]  A. Hausladen,et al.  Interactions of NO with hemoglobin: from microbes to man. , 2008, Methods in enzymology.

[38]  A. Gow,et al.  Biochemical Fates of α Hemoglobin Bound to α Hemoglobin-stabilizing Protein AHSP* , 2006, Journal of Biological Chemistry.

[39]  A. Gödecke.  On the impact of NO – globin interactions in the cardiovascular system , 2005 .

[40]  T. Iyanagi.  Structure and function of NADPH-cytochrome P450 reductase and nitric oxide synthase reductase domain. , 2005, Biochemical and biophysical research communications.

[41]  Andrew J. Gow,et al.  Structure of oxidized α-haemoglobin bound to AHSP reveals a protective mechanism for haem , 2005, Nature.

[42]  S. Moncada,et al.  Investigation of Vascular Responses in Endothelial Nitric Oxide Synthase/Cyclooxygenase-1 Double-Knockout Mice: Key Role for Endothelium-Derived Hyperpolarizing Factor in the Regulation of Blood Pressure in Vivo , 2005, Circulation.

[43]  Andrew J. Gow,et al.  Molecular Mechanism of AHSP-Mediated Stabilization of α-Hemoglobin , 2004, Cell.

[44]  A. Gow,et al.  Loss of α-hemoglobin–stabilizing protein impairs erythropoiesis and exacerbates β-thalassemia , 2004 .

[45]  D. Weatherall.  History of genetic disease: Thalassaemia: the long road from bedside to genome , 2004, Nature Reviews Genetics.

[46]  K. Keyvanfar,et al.  Efficient gene transfer into rhesus repopulating hematopoietic stem cells using a simian immunodeficiency virus-based lentiviral vector system. , 2004, Blood.

[47]  R. Popp,et al.  Changes in alpha-globin gene expression in mice of two alpha-globin haplotypes during development , 1990, Biochemical Genetics.

[48]  A. Gow,et al.  Loss of alpha-hemoglobin-stabilizing protein impairs erythropoiesis and exacerbates beta-thalassemia. , 2004, The Journal of clinical investigation.

[49]  Andrew J Gow,et al.  Molecular mechanism of AHSP-mediated stabilization of alpha-hemoglobin. , 2004, Cell.

[50]  M. Gladwin,et al.  Nitric oxide's reactions with hemoglobin: a view through the SNO-storm , 2003, Nature Medicine.

[51]  D. Gell,et al.  Biophysical Characterization of the α-Globin Binding Protein α-Hemoglobin Stabilizing Protein* , 2002, The Journal of Biological Chemistry.

[52]  G. Blobel,et al.  An abundant erythroid protein that stabilizes free α-haemoglobin , 2002, Nature.

[53]  Jody A. Vandergriff,et al.  Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[54]  G. Blobel,et al.  An abundant erythroid protein that stabilizes free alpha-haemoglobin. , 2002, Nature.

[55]  P. R. Gardner,et al.  Dioxygen-dependent metabolism of nitric oxide in mammalian cells. , 2001, Free radical biology & medicine.

[56]  J. Pollock,et al.  Functional expression of NOS 1 in vascular smooth muscle. , 2000, American journal of physiology. Heart and circulatory physiology.

[57]  R. Pedersen,et al.  Inactivation of mouse alpha-globin gene by homologous recombination: mouse model of hemoglobin H disease. , 1996, Blood.

[58]  M. Moskowitz,et al.  Hypertension in mice lacking the gene for endothelial nitric oxide synthase , 1995, Nature.

[59]  E W Singleton,et al.  The mechanism of autooxidation of myoglobin. , 1993, The Journal of biological chemistry.

[60]  P. Klatt,et al.  Ca2+/calmodulin-dependent cytochrome c reductase activity of brain nitric oxide synthase. , 1992, The Journal of biological chemistry.

[61]  F. Kuma.  Properties of methemoglobin reductase and kinetic study of methemoglobin reduction. , 1981, The Journal of biological chemistry.

[62]  M. Doyle,et al.  Oxidation of nitrogen oxides by bound dioxygen in hemoproteins. , 1981, Journal of inorganic biochemistry.

[63]  D E Hultquist,et al.  Catalysis of methaemoglobin reduction by erythrocyte cytochrome B5 and cytochrome B5 reductase. , 1971, Nature: New biology.